Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort

Sophie Gensluckner; Bernhard Wernly; Florian Koutny; Georg Strebinger; Stephan Zandanell; Lars Stechemesser; Bernhard Paulweber; Bernhard Iglseder; Eugen Trinka; Vanessa Frey; Patrick Langthaler; Georg Semmler; Luca Valenti; Elena Corradini; Christian Datz; Elmar Aigner

doi:10.3390/biomedicines12010207

Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort

Sophie Gensluckner, Bernhard Wernly (Co-author), Florian Koutny, Georg Strebinger, Stephan Zandanell (Co-author), Lars Stechemesser (Co-author), Bernhard Paulweber (Co-author), Bernhard Iglseder (Co-author), Eugen Trinka (Co-author), Vanessa Frey (Co-author), Patrick Langthaler (Co-author), Georg Semmler, Luca Valenti, Elena Corradini, Christian Datz, Elmar Aigner^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article (Journal) › peer-review

1 Citation (Web of Science)

Abstract

BACKGROUND: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort.

METHODS: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF.

RESULTS: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria.

CONCLUSION: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.

Original language	English
Number of pages	13
Journal	BIOMEDICINES
Volume	12
Issue number	1
DOIs	https://doi.org/10.3390/biomedicines12010207
Publication status	Published - 17 Jan 2024

Keywords

Fatty liver disease
Insulin resistance
Masld
Metabolic hyperferritinemia
Metabolic syndrome
Serum ferritin

Access to Document

10.3390/biomedicines12010207

Cite this

Gensluckner, S., Wernly, B., Koutny, F., Strebinger, G., Zandanell, S., Stechemesser, L., Paulweber, B., Iglseder, B., Trinka, E., Frey, V., Langthaler, P., Semmler, G., Valenti, L., Corradini, E., Datz, C., & Aigner, E. (2024). Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort. BIOMEDICINES, 12(1). https://doi.org/10.3390/biomedicines12010207

@article{389bd94ed7214256acce4d2e24606438,

title = "Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort",

abstract = "BACKGROUND: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort.METHODS: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF.RESULTS: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria.CONCLUSION: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.",

keywords = "Fatty liver disease, Insulin resistance, Masld, Metabolic hyperferritinemia, Metabolic syndrome, Serum ferritin",

author = "Sophie Gensluckner and Bernhard Wernly and Florian Koutny and Georg Strebinger and Stephan Zandanell and Lars Stechemesser and Bernhard Paulweber and Bernhard Iglseder and Eugen Trinka and Vanessa Frey and Patrick Langthaler and Georg Semmler and Luca Valenti and Elena Corradini and Christian Datz and Elmar Aigner",

note = "Lehr-KH Oberndorf; Genslucker, Strebinger, Zandanell, Stechemesser, Paulweber, Aigner: Department of Internal Medicine I, Paracelsus Medical University, M{\"u}llner Hauptstrasse 48, 5020 Salzburg, Austria; Gensluckner, Strebinger, Zandanell, Stechemesser, Aigner: Obesity Research Unit, Paracelsus Medical University, M{\"u}llner Hauptstrasse 48, 5020 Salzburg, Austria; Wernly, Datz: Department of Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University, Paracelsusstra{\ss}e 37, 5110 Oberndorf, Austria; Iglseder: Department of Geriatric Medicine, Christian Doppler University Hospital, Paracelsus Medical University, Ignaz-Harrer-Stra{\ss}e 79, 5020 Salzburg, Austria; Trinka, Frey, Langthaler: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Centre for Cognitive Neuroscience, Affiliated Member of the European Reference Network EpiCARE, Ignaz-Harrer-Stra{\ss}e 79, 5020 Salzburg, Austria",

year = "2024",

month = jan,

day = "17",

doi = "10.3390/biomedicines12010207",

language = "English",

volume = "12",

journal = "BIOMEDICINES",

issn = "2227-9059",

publisher = "MDPI",

number = "1",

}

Gensluckner, S, Wernly, B, Koutny, F, Strebinger, G, Zandanell, S , Stechemesser, L, Paulweber, B, Iglseder, B , Trinka, E , Frey, V, Langthaler, P, Semmler, G, Valenti, L, Corradini, E, Datz, C & Aigner, E 2024, 'Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort', BIOMEDICINES, vol. 12, no. 1. https://doi.org/10.3390/biomedicines12010207

TY - JOUR

T1 - Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort

AU - Gensluckner, Sophie

AU - Wernly, Bernhard

AU - Koutny, Florian

AU - Strebinger, Georg

AU - Zandanell, Stephan

AU - Stechemesser, Lars

AU - Paulweber, Bernhard

AU - Iglseder, Bernhard

AU - Trinka, Eugen

AU - Frey, Vanessa

AU - Langthaler, Patrick

AU - Semmler, Georg

AU - Valenti, Luca

AU - Corradini, Elena

AU - Datz, Christian

AU - Aigner, Elmar

N1 - Lehr-KH Oberndorf; Genslucker, Strebinger, Zandanell, Stechemesser, Paulweber, Aigner: Department of Internal Medicine I, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020 Salzburg, Austria; Gensluckner, Strebinger, Zandanell, Stechemesser, Aigner: Obesity Research Unit, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020 Salzburg, Austria; Wernly, Datz: Department of Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University, Paracelsusstraße 37, 5110 Oberndorf, Austria; Iglseder: Department of Geriatric Medicine, Christian Doppler University Hospital, Paracelsus Medical University, Ignaz-Harrer-Straße 79, 5020 Salzburg, Austria; Trinka, Frey, Langthaler: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Centre for Cognitive Neuroscience, Affiliated Member of the European Reference Network EpiCARE, Ignaz-Harrer-Straße 79, 5020 Salzburg, Austria

PY - 2024/1/17

Y1 - 2024/1/17

N2 - BACKGROUND: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort.METHODS: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF.RESULTS: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria.CONCLUSION: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.

AB - BACKGROUND: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort.METHODS: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF.RESULTS: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria.CONCLUSION: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.

KW - Fatty liver disease

KW - Insulin resistance

KW - Masld

KW - Metabolic hyperferritinemia

KW - Metabolic syndrome

KW - Serum ferritin

U2 - 10.3390/biomedicines12010207

DO - 10.3390/biomedicines12010207

M3 - Original Article (Journal)

C2 - 38255312

SN - 2227-9059

VL - 12

JO - BIOMEDICINES

JF - BIOMEDICINES

IS - 1

ER -

Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort

Abstract

Keywords

Access to Document

Fingerprint

Cite this